[Table/Fig-1]:

O and H agglutinins in the study groups

	All children	Group 1 (Widal +ve & clinically consistent)	Group 2 (Widal -ve & clinically consistent)	Group 3 (Widal +ve but not clinically consistent)	Group 4 (Widal –ve & not clinically consistent)
Titers	n=100 No. (%)	n= 42 No. (%)	n= 12 No. (%)	n=12 No. (%)	n= 34 No. (%)
Anti TO
≥ 400	08(8)	07(16.67)	00(0)	01(8.34)	00(0)
=200	08(8)	08(19.04)	00(0)	00(0)	00(0)
=100	10(10)	10(23.8)	00(0)	00(0)	00(0)
=50	28(28)	17(40.47)	00(0)	11(91.67)	00(0)
<50	46(46)	00(0)	12(100)	00(0)	34(100)
Anti TH
≥ 400	25(25)	23(54.76)	00(0)	02(16.67)	00(0)
=200	05(5)	04(9.52)	00(0)	01(8.34)	00(0)
=100	24(24)	15(35.71)	00(0)	09(75)	00(0)
=50	01(1)	00(0)	01(8.34)	00(0)	00(0)
<50	45(45)	00(0)	11(91.67)	00(0)	34(34)